chrX-53192985-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_004187.5(KDM5C):c.4665G>A(p.Pro1555Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000481 in 1,164,861 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 16 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.000048 ( 0 hom., 1 hem., cov: 20)
Exomes 𝑓: 0.000048 ( 0 hom. 15 hem. )
Consequence
KDM5C
NM_004187.5 synonymous
NM_004187.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.87
Genes affected
KDM5C (HGNC:11114): (lysine demethylase 5C) This gene is a member of the SMCY homolog family and encodes a protein with one ARID domain, one JmjC domain, one JmjN domain and two PHD-type zinc fingers. The DNA-binding motifs suggest this protein is involved in the regulation of transcription and chromatin remodeling. Mutations in this gene have been associated with X-linked cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant X-53192985-C-T is Benign according to our data. Variant chrX-53192985-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 1579968.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.87 with no splicing effect.
BS2
High Hemizygotes in GnomAdExome4 at 15 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KDM5C | NM_004187.5 | c.4665G>A | p.Pro1555Pro | synonymous_variant | 26/26 | ENST00000375401.8 | NP_004178.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KDM5C | ENST00000375401.8 | c.4665G>A | p.Pro1555Pro | synonymous_variant | 26/26 | 1 | NM_004187.5 | ENSP00000364550.4 |
Frequencies
GnomAD3 genomes AF: 0.0000477 AC: 5AN: 104849Hom.: 0 Cov.: 20 AF XY: 0.0000352 AC XY: 1AN XY: 28425
GnomAD3 genomes
AF:
AC:
5
AN:
104849
Hom.:
Cov.:
20
AF XY:
AC XY:
1
AN XY:
28425
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000201 AC: 3AN: 149261Hom.: 0 AF XY: 0.0000210 AC XY: 1AN XY: 47589
GnomAD3 exomes
AF:
AC:
3
AN:
149261
Hom.:
AF XY:
AC XY:
1
AN XY:
47589
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000481 AC: 51AN: 1060012Hom.: 0 Cov.: 33 AF XY: 0.0000440 AC XY: 15AN XY: 340910
GnomAD4 exome
AF:
AC:
51
AN:
1060012
Hom.:
Cov.:
33
AF XY:
AC XY:
15
AN XY:
340910
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000477 AC: 5AN: 104849Hom.: 0 Cov.: 20 AF XY: 0.0000352 AC XY: 1AN XY: 28425
GnomAD4 genome
AF:
AC:
5
AN:
104849
Hom.:
Cov.:
20
AF XY:
AC XY:
1
AN XY:
28425
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Spastic paraplegia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 04, 2023 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 30, 2019 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at